Elisabetta Vergani

1.2k citations
22 papers · 582 indexed · h-index 12
Topics
Extracellular vesicles in disease (7 papers)MicroRNA in disease regulation (5 papers)Cancer Immunotherapy and Biomarkers (5 papers)

In The Last Decade

Elisabetta Vergani

22 papers receiving 577 citations

Peers

Elisabetta Vergani
Comparison fields: 5 of 65
  • Molecular Biology 403
  • Cancer Research 207
  • Oncology 181
  • Immunology 179
  • Biomedical Engineering 59
Replace Alf Spitschak with:
Alf Spitschak Germany
Yunbin Ye China
Dmytro Starenki United States
Miaolin Zhu China
Chiara Bazzichetto Italy
Viola Allaj United States
Djamila Ouaret United Kingdom
Jianmei Hou China
Dorcas A. Annan Japan
He Dou China
Elisabetta Vergani relative to Alf Spitschak Germany Alf Spitschak's profile →
Citations per field
00.5×4.2×
Alf Spitschak · 1×
Citations per year

Countries citing papers authored by Elisabetta Vergani

Since Specialization
Citations

This map shows the geographic impact of Elisabetta Vergani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabetta Vergani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabetta Vergani more than expected).

Fields of papers citing papers by Elisabetta Vergani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabetta Vergani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabetta Vergani. The network helps show where Elisabetta Vergani may publish in the future.

Co-authorship network of co-authors of Elisabetta Vergani

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabetta Vergani. A scholar is included among the top collaborators of Elisabetta Vergani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabetta Vergani. Elisabetta Vergani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 7
3 3
4 1
5 16
6 4
7 18
8 37
9 20
10 3
11 18
12 7
13 16
14 8
15 41
16 164
17 8
18 22
19 34
20 71

About Elisabetta Vergani

Elisabetta Vergani is a scholar working on Cancer Research, Oncology and Immunology, having authored 22 papers that have together received 582 indexed citations. Recurring topics across this work include Extracellular vesicles in disease (7 papers), MicroRNA in disease regulation (5 papers) and Cancer Immunotherapy and Biomarkers (5 papers). The work is most often cited by research in Cancer Research (207 citations), Immunology (179 citations) and Oncology (181 citations). Elisabetta Vergani has collaborated with scholars based in Italy, United Kingdom and United States. Frequent co-authors include Monica Rodolfo, Licia Rivoltini, Veronica Huber, Viviana Vallacchi, Chiara Castelli, Barbara Vergani, Antonello Villa, Paola Perego, Simona Frigerio and Agata Cova. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026